Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibition of mitogen-activated protein kinase (MAPK) pathway: a selective therapeutic strategy against melanoma

Inhibition of mitogen-activated protein kinase (MAPK) pathway: a selective therapeutic strategy against melanoma

US Patent 7612035 · Granted Nov 3, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Wind blow type ground-based cloud seeding material generator for weather modific2025
Mig-6 knockout mice and elucidation of association of Mig-6 with early onset deg2013
Monoclonal antibody which binds cMet (HGFR) in formalin-fixed and paraffin-embed2012
Immune-compromised transgenic mice expressing human hepatocyte growth factor (hH2011
Monoclonal antibody which binds cMet (HGFR) in formalin-fixed and paraffin-embed2011
c-met siRNA adenovirus vectors inhibit cancer cell growth, invasion and tumorige2011
Anthrax lethal factor is a MAPK kinase protease2007
Anthrax lethal factor is a MAPK kinase protease2007
Anthrax lethal factor is a mapk kinase protease2006
Anthrax lethal factor is a MAPK kinase protease2005
Anthrax lethal factor is a MAPK kinase protease2005
Met proto-oncogene and a method for predicting breast cancer progression2004